Gut Microbiota and Pulmonary Tuberculosis (Literature Review)

Q4 Medicine

Tuberculosis and Lung Diseases Pub Date : 2024-05-02 DOI:10.58838/2075-1230-2024-102-2-86-96

N. V. Yukhimenko, S. Sterlikova, M. Gubkina, S. Kayukova

引用次数: 0

Abstract

The review analyzes 69 publications, of which 45 are devoted to studying gut microbiota in tuberculosis patients. The review presents data on the effect of gut microbiota disorders on the development of tuberculosis, severity and relapse rate. It covers the issues of changes in gut microbiota composition during anti-tuberculosis therapy and the effect of their management with probiotics on the tolerability of anti-tuberculosis therapy and effectiveness of treatment, including children.

查看原文本刊更多论文

肠道微生物群与肺结核（文献综述）

这篇综述分析了 69 篇出版物，其中 45 篇专门研究结核病患者的肠道微生物群。综述介绍了肠道微生物群紊乱对肺结核发病、严重程度和复发率的影响。它涵盖了抗结核治疗期间肠道微生物群组成的变化问题，以及用益生菌管理肠道微生物群对抗结核治疗的耐受性和治疗效果的影响，包括对儿童的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Tuberculosis and Lung Diseases Medicine-Pulmonary and Respiratory Medicine

CiteScore

1.20

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： The Journal is aimed for professional development of researchers, doctors, teachers of medical universities and training institutions. The Journal focuses on the presentation of results of research, case studies, issues of differential diagnostics and treatment in the phthisiologist’s practice, national programs on tuberculosis control in the Russian Federation, WHO strategies, discussion of prevention issues to stop transmission of TB/HIVco-infection, and extrapulmonary tuberculosis.